Bacterial resistance may be primary or secondary. Primary resistance occurs when patients not previously treated with anti-TB drugs, become infected from a patient with resistant TB. Secondary resistance occurs when anti-tuberculosis chemotherapy is used improperly: mono-therapy, insufficient dosage of time of R/ and poor compliance. Drug resistance leads to R/ failures and disease recurrence. DOT (Directly Observed Treatment) is called for, when poor compliance is suspected.